{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:38Z","timestamp":1786987718824,"version":"build-2736575974"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["963401"],"award-info":[{"award-number":["963401"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.drudis.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T11:31:11Z","timestamp":1568374271000},"page":"58-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome"],"prefix":"10.1016","volume":"25","author":[{"given":"Nasim","family":"Kiaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita Mahdavi","family":"Gorabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.09.005_bib0005","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2019.09.005_bib0010","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.drudis.2019.09.005_bib0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.09.005_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.09.005_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2011.03.025","article-title":"The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease","volume":"128","author":"Pamukcu","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0030","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2019.09.005_bib0035","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ncpcardio1247","article-title":"Arithmetic of vulnerable plaques for noninvasive imaging","volume":"5","author":"Narula","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"8 Suppl","key":"10.1016\/j.drudis.2019.09.005_bib0040","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/pmj.77.904.94","article-title":"New insights into atherosclerotic plaque rupture","volume":"77","author":"Braganza","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.drudis.2019.09.005_bib0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"25 Suppl. 2","key":"10.1016\/j.drudis.2019.09.005_bib0055","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2019.09.005_bib0060","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2019.09.005_bib0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1020178304031","article-title":"Biophysical aspects of using liposomes as delivery vehicles","volume":"22","author":"Ulrich","year":"2002","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.drudis.2019.09.005_bib0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.msec.2017.02.012","article-title":"Development of a DNA-liposome complex for gene delivery applications","volume":"75","author":"Rasoulianboroujeni","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.drudis.2019.09.005_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14797\/mdcj-8-1-36","article-title":"Liposomes in diagnosis and treatment of cardiovascular disorders","volume":"8","author":"Levchenko","year":"2012","journal-title":"Methodist Debakey Cardiovasc J."},{"key":"10.1016\/j.drudis.2019.09.005_bib0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/bc049949r","article-title":"A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets","volume":"15","author":"Mulder","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.drudis.2019.09.005_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15171\/bi.2018.08","article-title":"Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective","volume":"8","author":"Nakhlband","year":"2018","journal-title":"Bioimpacts"},{"key":"10.1016\/j.drudis.2019.09.005_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2006.08.049","article-title":"LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions","volume":"193","author":"Homem de Bittencourt","year":"2007","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.drudis.2019.09.005_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-3155-10-25","article-title":"Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent","volume":"10","author":"Paulis","year":"2012","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0105","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1182\/blood-2004-07-2617","article-title":"Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.09.005_bib0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(02)00236-X","article-title":"LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis","volume":"95","author":"Chen","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2019.09.005_bib0120","doi-asserted-by":"crossref","first-page":"O76","DOI":"10.1186\/1532-429X-11-S1-O76","article-title":"Molecular imaging of atherosclerotic plaque targeted to oxidized LDL receptor LOX-1 using magnetic resonance","volume":"11","author":"Li","year":"2009","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.drudis.2019.09.005_bib0125","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1593\/neo.08858","article-title":"Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes","volume":"10","author":"van Tilborg","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.drudis.2019.09.005_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2014.11.024","article-title":"Minimizing antibody surface density on liposomes while sustaining cytokine-activated EC targeting","volume":"41","author":"Almeda","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2019.09.005_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbamem.2005.02.007","article-title":"Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity","volume":"1711","author":"Laginha","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.09.005_bib0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2006.05.028","article-title":"A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers","volume":"114","author":"Saul","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.09.005_bib0145","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1016\/j.biomaterials.2011.08.093","article-title":"Complementary targeting of liposomes to IL-1alpha and TNF-alpha activated endothelial cells via the transient expression of VCAM1 and E-selectin","volume":"32","author":"Gunawan","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2019.09.005_bib0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/mp300316n","article-title":"Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes","volume":"10","author":"Almer","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jbiomech.2016.11.015","article-title":"Shear targeted drug delivery to stenotic blood vessels","volume":"50","author":"Epshtein","year":"2017","journal-title":"J. Biomech."},{"key":"10.1016\/j.drudis.2019.09.005_bib0160","first-page":"323","article-title":"Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells","volume":"46","author":"Calderon","year":"2009","journal-title":"Biorheology"},{"key":"10.1016\/j.drudis.2019.09.005_bib0165","doi-asserted-by":"crossref","first-page":"R795","DOI":"10.1016\/S0960-9822(01)00474-2","article-title":"Apoptotic cell removal","volume":"11","author":"Henson","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2019.02.001","article-title":"Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system","volume":"283","author":"Momtazi-Borojeni","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drudis.2019.09.005_bib0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2967\/jnumed.113.123158","article-title":"Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging","volume":"55","author":"Ogawa","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0180","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1074\/jbc.274.5.3048","article-title":"Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells","volume":"274","author":"Tait","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.09.005_bib0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.drudis.2019.09.005_bib0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.09.005_bib0195","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.2174\/1389201011208062435","article-title":"The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis","volume":"13","author":"Jawien","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/08982104.2013.863208","article-title":"Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue","volume":"24","author":"Zhaorigetu","year":"2014","journal-title":"Liposome Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0205","first-page":"1279","article-title":"Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques","volume":"6","author":"Almer","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.drudis.2019.09.005_bib0210","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2010.11.011","article-title":"Adiponectin and vulnerable atherosclerotic plaques","volume":"57","author":"Barseghian","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0215","first-page":"1006413","article-title":"Assessment of plaque vulnerability in atherosclerosis via intravascular photoacoustic imaging of targeted liposomal ICG J-aggregates","volume":"10064","author":"Harris","year":"2017","journal-title":"SPIE BiOS"},{"key":"10.1016\/j.drudis.2019.09.005_bib0220","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s10439-009-9702-5","article-title":"Selective targeting of nanocarriers to neutrophils and monocytes","volume":"37","author":"Karathanasis","year":"2009","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.drudis.2019.09.005_bib0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/protein\/gzh055","article-title":"Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells","volume":"17","author":"Holig","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.drudis.2019.09.005_bib0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(03)00269-2","article-title":"RGD-anchored magnetic liposomes for monocytes\/neutrophils-mediated brain targeting","volume":"261","author":"Jain","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0235","doi-asserted-by":"crossref","first-page":"727241","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.drudis.2019.09.005_bib0240","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1039\/C4TB00701H","article-title":"Co-liposomes comprising a lipidated multivalent RGD-peptide and a cationic gemini cholesterol induce selective gene transfection in \u03b1v\u03b23 and \u03b1v\u03b25 integrin receptor-rich cancer cells","volume":"2","author":"Misra","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.drudis.2019.09.005_bib0245","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/IJN.S125573","article-title":"Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects","volume":"12","author":"Song","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drudis.2019.09.005_bib0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/LPR-120004782","article-title":"Interference of macrophages with immunotargeting of liposomes","volume":"12","author":"Koning","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0769-2625(87)80054-5","article-title":"Use of mannosylated liposomes for in vivo targeting of a macrophage activator and control of artificial pulmonary metastases","volume":"138","author":"Barratt","year":"1987","journal-title":"Ann. Inst. Pasteur Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2019.09.005_bib0260","first-page":"1204","article-title":"Effect of mannose ligand of manosylated liposomes on targeting for macrophage cell","volume":"55","author":"Jeong","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301089","article-title":"Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes","volume":"7","author":"Kawakami","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2019.09.005_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2007.10.011","article-title":"Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats","volume":"125","author":"Wijagkanalan","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.09.005_bib0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.drudis.2019.09.005_bib0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13550-019-0474-0","article-title":"Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 68Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques","volume":"9","author":"Varasteh","year":"2019","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/js9603515","article-title":"In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement","volume":"86","author":"Demos","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2019.09.005_bib0290","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0735-1097(98)00607-X","article-title":"In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement","volume":"33","author":"Demos","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0295","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/10611869808997876","article-title":"In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions","volume":"5","author":"Demos","year":"1998","journal-title":"J. Drug Target"},{"key":"10.1016\/j.drudis.2019.09.005_bib0300","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature06803","article-title":"Imaging of atherosclerotic cardiovascular disease","volume":"451","author":"Sanz","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.09.005_bib0305","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000861","article-title":"Applying the ordinal model of atherosclerosis to imaging science: a brief review","volume":"5","author":"Groenendyk","year":"2018","journal-title":"Open Heart."},{"key":"10.1016\/j.drudis.2019.09.005_bib0310","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCRESAHA.115.306247","article-title":"Imaging atherosclerosis","volume":"118","author":"Tarkin","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0315","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2019.09.005_bib0320","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1039\/C9NR00207C","article-title":"Liposome-based probes for molecular imaging: from basic research to the bedside","volume":"11","author":"Xia","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2019.09.005_bib0325","series-title":"International Conference on Photonics and Imaging in Biology and Medicine","article-title":"Nanoliposomes for photodynamic therapy guided by fluorescence and computed tomography imaging","author":"Xu","year":"2017"},{"key":"10.1016\/j.drudis.2019.09.005_bib0330","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004424-200106000-00001","article-title":"Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging","volume":"36","author":"Leike","year":"2001","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0335","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/08982104.2010.527852","article-title":"CT imaging with iopromide liposomes in a rabbit model","volume":"21","author":"Krause","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0340","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5012\/jkcs.2013.57.5.634","article-title":"Preparation of gold coated liposomes for CT contrast medium","volume":"57","author":"In Wee","year":"2013","journal-title":"J. Korean Chem. Soc."},{"key":"10.1016\/j.drudis.2019.09.005_bib0345","first-page":"393","article-title":"Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography","volume":"36","author":"Danila","year":"2009","journal-title":"Tex. Heart Inst. J."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2019.09.005_bib0350","first-page":"186","article-title":"PET\/MRI to predict and quantify the uptake of 89Zr-labeled nanoparticles in the aortic wall of atherosclerotic rabbits","volume":"55","author":"Binderup","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal delivery systems: design optimization and current applications","volume":"40","author":"Abu Lila","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.drudis.2019.09.005_bib0360","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1194\/jlr.M800405-JLR200","article-title":"Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis","volume":"50","author":"Maiseyeu","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0365","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/mrm.20883","article-title":"Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse","volume":"55","author":"Mulder","year":"2006","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0370","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/s41598-018-21893-x","article-title":"Magnetic resonance imaging of atherosclerotic plaque at clinically relevant field strengths (1T) by targeting the integrin \u03b14\u03b21","volume":"8","author":"Woodside","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.09.005_bib0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cmmi.402","article-title":"Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque","volume":"6","author":"van Bochove","year":"2011","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.drudis.2019.09.005_bib0380","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41598-017-01649-9","article-title":"Real-time intravascular photoacoustic-ultrasound imaging of lipid-laden plaque in human coronary artery at 16 frames per second","volume":"7","author":"Hui","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.09.005_bib0385","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ultrasmedbio.2014.01.008","article-title":"Intravascular photoacoustic imaging: a new tool for vulnerable plaque identification","volume":"40","author":"Jansen","year":"2014","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0390","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/js950407f","article-title":"Development of inherently echogenic liposomes as an ultrasonic contrast agent","volume":"85","author":"Alkan-Onyuksel","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2019.09.005_bib0395","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9120(97)00098-2","article-title":"Reverse cholesterol transport--a review of the process and its clinical implications","volume":"30","author":"Hill","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.drudis.2019.09.005_bib0400","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/1358863x05vm593ra","article-title":"ABCA1 and atherosclerosis","volume":"10","author":"Soumian","year":"2005","journal-title":"Vasc. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0405","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1002\/jcp.26610","article-title":"Anionic nanoliposomes reduced atherosclerosis progression in low density lipoprotein receptor (LDLR) deficient mice fed a high fat diet","volume":"233","author":"Krishna","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0410","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.colsurfb.2014.07.045","article-title":"A simple and effective approach for the treatment of dyslipidemia using anionic nanoliposomes","volume":"122","author":"Sahebkar","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.drudis.2019.09.005_bib0415","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.colsurfb.2015.03.012","article-title":"Apolipoprotein B-100-targeted negatively charged nanoliposomes for the treatment of dyslipidemia","volume":"129","author":"Sahebkar","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.drudis.2019.09.005_bib0420","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0425","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1258\/ebm.2010.009320","article-title":"Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits","volume":"235","author":"Cho","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2019.09.005_bib0435","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.biopha.2016.12.009","article-title":"Heart targeted nanoliposomal\/nanoparticles drug delivery: an updated review","volume":"86","author":"Cheraghi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drudis.2019.09.005_bib0440","first-page":"518","article-title":"Novel nanomedicine for anti-inflammatory therapy of atherosclerosis monitored by multimodality imaging","volume":"16","author":"Lobatto","year":"2019","journal-title":"Proc. Intl. Soc. Mag. Reson. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0445","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/mp100309y","article-title":"Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis","volume":"7","author":"Lobatto","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0450","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.108.170662","article-title":"Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma","volume":"28","author":"Joner","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0455","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.nano.2016.02.022","article-title":"Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis","volume":"12","author":"van der Valk","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2019.09.005_bib0460","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.nano.2015.02.021","article-title":"Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration","volume":"11","author":"van der Valk","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2019.09.005_bib0465","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10611860500159030","article-title":"Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice","volume":"13","author":"Chono","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.drudis.2019.09.005_bib0470","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2014.11.016","article-title":"VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes","volume":"89","author":"Calin","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0475","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.atherosclerosis.2015.04.306","article-title":"Targeted liposomal drug delivery to inhibit atherosclerotic plaque inflammation","volume":"241","author":"Alaarg","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drudis.2019.09.005_bib0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosissup.2018.04.021","article-title":"The anti-atherogenic potential of liposome-mediated delivery of LXR agonists to macrophages: a preclinical validation study","volume":"32","author":"Hoekstra","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drudis.2019.09.005_bib0485","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/08982104.2015.1029494","article-title":"Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression","volume":"26","author":"Klegerman","year":"2016","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190540","article-title":"Anti-angiogenic drug loaded liposomes: nanotherapy for early atherosclerotic lesions in mice","volume":"13","author":"Pont","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.09.005_bib0495","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1016\/j.vaccine.2009.08.105","article-title":"Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines","volume":"27","author":"Steers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2019.09.005_bib0500","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/112_2018_9","article-title":"Potential of cationic liposomes as adjuvants\/delivery systems for tuberculosis subunit vaccines","volume":"175","author":"Khademi","year":"2018","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0505","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1002\/jcp.26361","article-title":"Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy","volume":"233","author":"Zamani","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0510","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1091\/mbc.8.12.2631","article-title":"Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation","volume":"8","author":"Raposo","year":"1997","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.drudis.2019.09.005_bib0515","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvv037","article-title":"Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes","volume":"106","author":"Hosseini","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0520","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/2051013617693753","article-title":"Vaccine against arteriosclerosis: an update","volume":"5","author":"Chyu","year":"2017","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.drudis.2019.09.005_bib0525","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2018.10.028","article-title":"Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice","volume":"291","author":"Benne","year":"2018","journal-title":"J. Control. Release"},{"issue":"1 Suppl","key":"10.1016\/j.drudis.2019.09.005_bib0530","article-title":"Stimulating antigen-specific regulatory T cells for an atherosclerosis vaccine","volume":"196","author":"Benne","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0535","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-2143(96)90164-X","article-title":"Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation","volume":"127","author":"Alving","year":"1996","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0540","first-page":"403","article-title":"Influence of cholesterol liposome immunisation and immunostimulation on rabbits atherosclerosis induced by a high cholesterol diet","volume":"4","author":"Horva","year":"1998","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.drudis.2019.09.005_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp900116r","article-title":"Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1","volume":"7","author":"Herbst","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0550","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2010.02.030","article-title":"Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model","volume":"144","author":"Hitchcock","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.09.005_bib0555","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosissup.2018.04.439","article-title":"Nanoliposomes for safe and efficient therapeutic CD39 mRNA delivery: prevention and treatment of inflammatory and cardiovascular diseases","volume":"32","author":"Xiaowei","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drudis.2019.09.005_bib0560","doi-asserted-by":"crossref","first-page":"A2118","DOI":"10.1016\/S0735-1097(14)62121-5","article-title":"Delivery of liposomal fatty acid binding protein 4 siRNA for the treatment of atherosclerosis in apolipoprotein E-deficient mice","volume":"63","author":"Zhaorigetu","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0565","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/mp4001124","article-title":"Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells","volume":"10","author":"Kowalski","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2019.09.005_bib0570","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1053-2498(00)00203-5","article-title":"Effects of human tissue plasminogen gene transfer on allograft coronary atherosclerosis","volume":"20","author":"Scholl","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.drudis.2019.09.005_bib0575","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drudis.2019.09.005_bib0580","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s11095-017-2097-3","article-title":"The effect of surface charges on the cellular uptake of liposomes investigated by live cell imaging","volume":"34","author":"Kang","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2019.09.005_bib0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1358863X10374118","article-title":"Delivery of negatively charged liposomes into the atheromas of Watanabe heritable hyperlipidemic rabbits","volume":"15","author":"Walton","year":"2010","journal-title":"Vasc. Med."},{"key":"10.1016\/j.drudis.2019.09.005_bib0590","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20111708","article-title":"Role and function of macrophages in the metabolic syndrome","volume":"442","author":"Bhargava","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2019.09.005_bib0595","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/096876899294823","article-title":"Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection","volume":"16","author":"de Lima","year":"1999","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0600","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12410-011-9114-4","article-title":"Molecular MRI of inflammation in atherosclerosis","volume":"5","author":"Te Boekhorst","year":"2012","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"10.1016\/j.drudis.2019.09.005_bib0605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.atherosclerosis.2018.03.021","article-title":"New methods to image unstable atherosclerotic plaques","volume":"272","author":"Andrews","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drudis.2019.09.005_bib0610","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MOL.0000000000000350","article-title":"The future of imaging in cardiovascular disease intervention trials: (2017 and beyond)","volume":"27","author":"Doris","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.drudis.2019.09.005_bib0615","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11307-014-0798-0","article-title":"Noninvasive detection of macrophages in atheroma using a radiocontrast-loaded phosphatidylserine-containing liposomal contrast agent for computed tomography","volume":"17","author":"Kee","year":"2015","journal-title":"Mol. Imaging Biol."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644619303496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644619303496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:43:31Z","timestamp":1761223411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644619303496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1359644619303496"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.09.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}